Slide 1Failure Prof. Nathan CLUMECK Head, Department of infectious diseases Saint-Pierre University Hospital Brussels, Belgium 6th EACS Advanced HIV Course Montpellier, Sept.…
1. Boosted Protease Inhibitors:Current and Future Role in HIVTherapyThis activity is supported by an independent educationalgrant from Janssen Therapeutics 2. Boosted Protease…
Slide 1 Study sponsors LASA: Low dose Atazanavir/r vs. Standard dose Atazanavir/r The LASA study Atazanavir/ritonavir 200/100 mg is Non-inferior to 300/100 mg in Virologic…
Slide 1 Efficacy of maraviroc (MVC) administered once-daily or twice-daily with boosted protease inhibitors to treatment-experienced patients S Taylor,1 J Arribas,2 C-F Perno,3…